BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36085204)

  • 1. Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma.
    Ketpueak T; Chanloung W; Nan KN; Pongsananurak C; Kasitanon N; Louthrenoo W
    Clin Rheumatol; 2022 Dec; 41(12):3887-3896. PubMed ID: 36085204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis following COVID-19 infection with recurrent corticosteroid-induced scleroderma renal crisis.
    Carroll M; Nagarajah V; Campbell S
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36931690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma-like cutaneous lesions induced by paclitaxel: a case study.
    Kupfer I; Balguerie X; Courville P; Chinet P; Joly P
    J Am Acad Dermatol; 2003 Feb; 48(2):279-81. PubMed ID: 12582404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features and prognosis of patients with scleroderma renal crisis].
    Roda-Safont A; Simeón-Aznar CP; Fonollosa-Plà V; Segarra-Medrano A; Vilardell-Tarrés M
    Med Clin (Barc); 2011 Oct; 137(10):431-4. PubMed ID: 21596402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and localized scleroderma in children: current and future treatment options.
    Rosenkranz ME; Agle LM; Efthimiou P; Lehman TJ
    Paediatr Drugs; 2006; 8(2):85-97. PubMed ID: 16608370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleroderma in association with the use of docetaxel (taxotere) for breast cancer.
    Hassett G; Harnett P; Manolios N
    Clin Exp Rheumatol; 2001; 19(2):197-200. PubMed ID: 11326485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 45-Year-Old Man with Scleroderma Renal Crisis Associated with a History of Systemic Sclerosis Sine Scleroderma.
    Hansrivijit P; Omeonu KF; Lawal HO; Gangireddy M; Gadhiya KP; Dhatt RS
    Am J Case Rep; 2020 Nov; 21():e927030. PubMed ID: 33230093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleroderma-like cutaneous lesions induced by paclitaxel and carboplatin for ovarian carcinoma, not a single course of carboplatin, but re-induced and worsened by previously administrated paclitaxel.
    Konishi Y; Sato H; Sato N; Fujimoto T; Fukuda J; Tanaka T
    J Obstet Gynaecol Res; 2010 Jun; 36(3):693-6. PubMed ID: 20598060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Scleroderma-like skin changes following administration of paclitaxel for the treatment of ovarian carcinoma].
    Eisenbeilss C; Weizel J; Wolff H
    J Dtsch Dermatol Ges; 2003 Jun; 1(6):468-70. PubMed ID: 16295141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleroderma renal crisis with minimal skin involvement and no serologic evidence of systemic sclerosis.
    Gonzalez EA; Schmulbach E; Bastani B
    Am J Kidney Dis; 1994 Feb; 23(2):317-9. PubMed ID: 8311093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic Scleroderma: Are There Any Clues?
    Jedlickova H; Durčanská V; Vašků V
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):78-80. PubMed ID: 27149136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis in the absence of skin disease.
    Bhavsar SV; Carmona R
    J Clin Rheumatol; 2014 Oct; 20(7):379-82. PubMed ID: 25275766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "silent" course of normotensive scleroderma renal crisis: case report and review of the literature.
    Akoglu H; Atilgan GK; Ozturk R; Yenigun EC; Gonul II; Odabas AR
    Rheumatol Int; 2009 Aug; 29(10):1223-9. PubMed ID: 19048256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxane-induced scleroderma.
    Itoh M; Yanaba K; Kobayashi T; Nakagawa H
    Br J Dermatol; 2007 Feb; 156(2):363-7. PubMed ID: 17223879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of salt and pepper skin changes in diffuse scleroderma after treatment with tofacitinib.
    Nallapati A; Wigley FM; Paik JJ
    Clin Exp Rheumatol; 2022 Oct; 40(10):2008-2009. PubMed ID: 36189907
    [No Abstract]   [Full Text] [Related]  

  • 16. Taxane-induced scleroderma. Report of two cases.
    Cury-Martins J; Giesen L; González S; Molgo M; Sanches JA
    Rev Med Chil; 2021 May; 149(5):807-809. PubMed ID: 34751336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced scleroderma-like lesion.
    Hamaguchi Y
    Allergol Int; 2022 Apr; 71(2):163-168. PubMed ID: 34465533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachial plexopathy associated with diffuse edematous scleroderma.
    Mouthon L; Halimi C; Dussaule Md JC; Cayre-Castel Md M; Guillevin L
    Ann Med Interne (Paris); 2000 Jun; 151(4):303-5. PubMed ID: 10922959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis, management and prevention of scleroderma renal disease.
    Penn H; Denton CP
    Curr Opin Rheumatol; 2008 Nov; 20(6):692-6. PubMed ID: 18946330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
    Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
    J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.